Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

China · Delayed Price · Currency is CNY

47.17

+0.23 (0.49%)

At close: Jun 11, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Implanted Medical Devices	356.00M	271.50M	224.59M	189.45M	147.60M
Implanted Medical Devices Growth	31.12%	20.89%	18.55%	28.35%	22.54%
Others	12.83M	6.95M	6.28M	5.80M	6.18M
Others Growth	84.79%	10.57%	8.31%	-6.18%	102.20%
Total	368.83M	278.44M	230.87M	195.25M	153.79M
Total Growth	32.46%	20.61%	18.24%	26.96%	24.51%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	282.73M	221.75M	180.82M	159.28M	131.65M
China Growth	27.50%	22.63%	13.53%	20.99%	20.60%
Overseas	86.10M	56.69M	50.05M	35.98M	22.14M
Overseas Growth	51.87%	13.28%	39.11%	62.51%	54.24%
Total	368.83M	278.44M	230.87M	195.25M	153.79M
Total Growth	32.46%	20.61%	18.24%	26.96%	24.51%

Source: S&P Global Market Intelligence.